(HealthDay News) — For pregnant women with pre-existing diabetes, falling insulin requirement (FIR) is associated with altered expression of placental antiangiogenic factors and preeclampsia, according to a study published online in Diabetes Care.
Suja Padmanabhan, MBBS, MPH, from Westmead Hospital in Sydney, and colleagues conducted a multicenter cohort study involving 158 pregnant women with pre-existing diabetes (41 with type 1 and 117 with type 2). Thirty-two women had FIR of ≥15% from the peak total daily dose after 20 weeks of gestation and were considered case subjects. The primary outcome was a composite of clinical markers of placental dysfunction.
The researchers found that FIR ≥15% correlated with an increased risk of the composite primary outcome (odds ratio, 4.38) and preeclampsia (odds ratio, 6.76), and was more common among women with type 1 diabetes (36.6% vs 14.5%). Women with FIR ≥15% had modestly elevated creatinine; no difference was seen in hemoglobin A1c. Among women with FIR at 25, 30, and 36 weeks, the ratio of soluble fms-like tyrosine kinase 1 to placental growth factor was significantly higher, with differences maintained among those who developed preeclampsia. No difference was seen in placental hormones between the groups.
“FIR is an important clinical sign, among women with pre-existing diabetes, that should alert the clinician to investigate underlying placental dysfunction,” the authors write.
- Padmanabhan S, Lee VW, Mclean M, et al. The Association of Falling Insulin Requirements With Maternal Biomarkers and Placental Dysfunction: A Prospective Study of Women With Pre-existing Diabetes in Pregnancy. Diabetes Care. 10 August 2017. doi: 10.2337/dc17-0391